|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||67.50 - 69.22|
|52-week range||67.50 - 69.22|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||26.16|
|Forward dividend & yield||N/A (N/A)|
|1y target est||110.09|
LUXEMBOURG, January 18, 2023--Regulatory News: Eurofins Scientific SE (Paris:ERF):
LUXEMBOURG, January 17, 2023--Regulatory News: Eurofins Scientific (EUFI.PA, rated Baa3 by Moody’s and BBB- by Fitch, "Eurofins") (Paris:ERF), a global leader in bioanalytical testing, announces that it has successfully raised €600m in its latest Euro hybrid bond public issuance. The transaction was well received and more than 2.7x times over-subscribed.
MISSISSAUGA, Canada, January 11, 2023--Eurofins CDMO Alphora Inc. is pleased to announce the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.